Children's Hospital Association submitted comments on the cell and gene therapy request for information (RFI) from Sen. Bill Cassidy (R-La.), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee. Our response highlights the need to ensure children’s equitable access to these therapies and a strong national framework for payment and oversight.
CHA Response to Cell and Gene Therapy RFI
Cell and gene therapies have the potential to address unmet pediatric medical needs, reduce the need for costly chronic care, and help address health disparities.
Related Content
Securing Kids' Futures Requires Strengthening the Pediatric Workforce
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
Securing Kids' Futures Requires Strengthening the Pediatric Workforce
Children’s hospitals are focused on building a workforce to meet children’s needs today and into the future.
March 04, 2026
Protecting 340B Allows Hospitals to Invest Millions in Children's Health
A recent assessment showed children’s hospitals participating in the federal drug pricing discount program save hundreds of millions annually — and invest even more into their communities.
March 03, 2026
CHA Responds to 2 CMS Rules Impacting Access to Care for Children
CHA responded to two proposed rules on Medicaid funding and Hospital Conditions of Participation.
Feb. 18, 2026
